497 related articles for article (PubMed ID: 32295417)
1. Effects of Acute Colchicine Administration Prior to Percutaneous Coronary Intervention: COLCHICINE-PCI Randomized Trial.
Shah B; Pillinger M; Zhong H; Cronstein B; Xia Y; Lorin JD; Smilowitz NR; Feit F; Ratnapala N; Keller NM; Katz SD
Circ Cardiovasc Interv; 2020 Apr; 13(4):e008717. PubMed ID: 32295417
[TBL] [Abstract][Full Text] [Related]
2. PAR1 (Protease-Activated Receptor 1) Pepducin Therapy Targeting Myocardial Necrosis in Coronary Artery Disease and Acute Coronary Syndrome Patients Undergoing Cardiac Catheterization: A Randomized, Placebo-Controlled, Phase 2 Study.
Kuliopulos A; Gurbel PA; Rade JJ; Kimmelstiel CD; Turner SE; Bliden KP; Fletcher EK; Cox DH; Covic L;
Arterioscler Thromb Vasc Biol; 2020 Dec; 40(12):2990-3003. PubMed ID: 33028101
[TBL] [Abstract][Full Text] [Related]
3. Long-Term Effect of Ultrathin-Strut Versus Thin-Strut Drug-Eluting Stents in Patients With Small Vessel Coronary Artery Disease Undergoing Percutaneous Coronary Intervention: A Subgroup Analysis of the BIOSCIENCE Randomized Trial.
Iglesias JF; Heg D; Roffi M; Tüller D; Noble S; Muller O; Moarof I; Cook S; Weilenmann D; Kaiser C; Cuculi F; Häner J; Jüni P; Windecker S; Pilgrim T
Circ Cardiovasc Interv; 2019 Aug; 12(8):e008024. PubMed ID: 31525083
[TBL] [Abstract][Full Text] [Related]
4. B-Type Natriuretic Peptide Assessment in Patients Undergoing Revascularization for Left Main Coronary Artery Disease: Analysis From the EXCEL Trial.
Redfors B; Chen S; Crowley A; Ben-Yehuda O; Gersh BJ; Lembo NJ; Brown WM; Banning AP; Taggart DP; Serruys PW; Kappetein AP; Sabik JF; Stone GW
Circulation; 2018 Jul; 138(5):469-478. PubMed ID: 29666071
[TBL] [Abstract][Full Text] [Related]
5. Colchicine to Prevent Periprocedural Myocardial Injury in Percutaneous Coronary Intervention: The COPE-PCI Pilot Trial.
Cole J; Htun N; Lew R; Freilich M; Quinn S; Layland J
Circ Cardiovasc Interv; 2021 May; 14(5):e009992. PubMed ID: 34003667
[TBL] [Abstract][Full Text] [Related]
6. Left Main Coronary Artery Disease Revascularization According to the SYNTAX Score.
Shlofmitz E; Généreux P; Chen S; Dressler O; Ben-Yehuda O; Morice MC; Puskas JD; Taggart DP; Kandzari DE; Crowley A; Redfors B; Mehdipoor G; Kappetein AP; Sabik JF; Serruys PW; Stone GW
Circ Cardiovasc Interv; 2019 Sep; 12(9):e008007. PubMed ID: 31495220
[TBL] [Abstract][Full Text] [Related]
7. COlchicine to Prevent PeriprocEdural Myocardial Injury in Percutaneous Coronary Intervention (COPE-PCI): A Descriptive Cytokine Pilot Sub-Study.
Cole J; Htun N; Lew R; Freilich M; Quinn S; Layland J
Cardiovasc Revasc Med; 2022 Jun; 39():84-89. PubMed ID: 34686461
[TBL] [Abstract][Full Text] [Related]
8. Routine Fractional Flow Reserve Measurement After Percutaneous Coronary Intervention.
van Bommel RJ; Masdjedi K; Diletti R; Lemmert ME; van Zandvoort L; Wilschut J; Zijlstra F; de Jaegere P; Daemen J; van Mieghem NM
Circ Cardiovasc Interv; 2019 May; 12(5):e007428. PubMed ID: 31018666
[TBL] [Abstract][Full Text] [Related]
9. Effects of colchicine on major adverse cardiac events in next 6-month period after acute coronary syndrome occurrence; a randomized placebo-control trial.
Akrami M; Izadpanah P; Bazrafshan M; Hatamipour U; Nouraein N; Drissi HB; Manafi A
BMC Cardiovasc Disord; 2021 Dec; 21(1):583. PubMed ID: 34876021
[TBL] [Abstract][Full Text] [Related]
10. Remote ischemic preconditioning immediately before percutaneous coronary intervention does not impact myocardial necrosis, inflammatory response, and circulating endothelial progenitor cell counts: a single center randomized sham controlled trial.
Prasad A; Gössl M; Hoyt J; Lennon RJ; Polk L; Simari R; Holmes DR; Rihal CS; Lerman A
Catheter Cardiovasc Interv; 2013 May; 81(6):930-6. PubMed ID: 22517646
[TBL] [Abstract][Full Text] [Related]
11. Prognostic Effects of Treatment Strategies for Left Main Versus Non-Left Main Bifurcation Percutaneous Coronary Intervention With Current-Generation Drug-Eluting Stent.
Choi KH; Song YB; Lee JM; Park TK; Yang JH; Hahn JY; Choi JH; Choi SH; Kim HS; Chun WJ; Hur SH; Han SH; Rha SW; Chae IH; Jeong JO; Heo JH; Yoon J; Lim DS; Park JS; Hong MK; Doh JH; Cha KS; Kim DI; Lee SY; Chang K; Hwang BH; Choi SY; Jeong MH; Hong SJ; Nam CW; Koo BK; Gwon HC
Circ Cardiovasc Interv; 2020 Feb; 13(2):e008543. PubMed ID: 32069106
[TBL] [Abstract][Full Text] [Related]
12. Safety and Efficacy of Polymer-Free Biolimus A9-Coated Versus Bare-Metal Stents in Orally Anticoagulated Patients: 2-Year Results of the LEADERS FREE Oral Anticoagulation Substudy.
Carrié D; Menown I; Oldroyd K; Copt S; Talwar S; Maillard L; Morice MC; Teik LS; Lang I; Urban P
JACC Cardiovasc Interv; 2017 Aug; 10(16):1633-1642. PubMed ID: 28838473
[TBL] [Abstract][Full Text] [Related]
13. Subgroup Analysis Comparing Ultrathin, Bioresorbable Polymer Sirolimus-Eluting Stents Versus Thin, Durable Polymer Everolimus-Eluting Stents in Acute Coronary Syndrome Patients.
Roguin A; Kandzari DE; Marcusohn E; Koolen JJ; Doros G; Massaro JM; Garcia-Garcia HM; Bennett J; Gharib EG; Cutlip DE; Waksman R
Circ Cardiovasc Interv; 2018 Oct; 11(10):e007331. PubMed ID: 30354631
[TBL] [Abstract][Full Text] [Related]
14. Preprocedural statin therapy, inflammation, and myocardial injury in low-risk stable coronary artery disease patients submitted to coronary stent implantation.
Greque GV; Serrano CV; Strunz CM; Soeiro A; Santos M; Pivateli F; Jacob JL; Pesaro AE; Nicolau JC; Kalil-Filho R
Catheter Cardiovasc Interv; 2016 Feb; 87(2):222-9. PubMed ID: 23592528
[TBL] [Abstract][Full Text] [Related]
15. Colchicine Inhibits Neutrophil Extracellular Trap Formation in Patients With Acute Coronary Syndrome After Percutaneous Coronary Intervention.
Vaidya K; Tucker B; Kurup R; Khandkar C; Pandzic E; Barraclough J; Machet J; Misra A; Kavurma M; Martinez G; Rye KA; Cochran BJ; Patel S
J Am Heart Assoc; 2021 Jan; 10(1):e018993. PubMed ID: 33346683
[TBL] [Abstract][Full Text] [Related]
16. Colchicine in Patients With Acute Coronary Syndrome: The Australian COPS Randomized Clinical Trial.
Tong DC; Quinn S; Nasis A; Hiew C; Roberts-Thomson P; Adams H; Sriamareswaran R; Htun NM; Wilson W; Stub D; van Gaal W; Howes L; Collins N; Yong A; Bhindi R; Whitbourn R; Lee A; Hengel C; Asrress K; Freeman M; Amerena J; Wilson A; Layland J
Circulation; 2020 Nov; 142(20):1890-1900. PubMed ID: 32862667
[TBL] [Abstract][Full Text] [Related]
17. Duration of Triple Antithrombotic Therapy and Outcomes Among Patients Undergoing Percutaneous Coronary Intervention.
Koskinas KC; Räber L; Zanchin T; Pilgrim T; Stortecky S; Hunziker L; Blöchlinger S; Billinger M; Gartwyl F; Moro C; Moschovitis A; Jüni P; Heg D; Windecker S
JACC Cardiovasc Interv; 2016 Jul; 9(14):1473-83. PubMed ID: 27478115
[TBL] [Abstract][Full Text] [Related]
18. Percutaneous Coronary Intervention for Left Main Coronary Disease in New Zealand: National Linkage Study of Characteristics and In-Hospital Outcomes (ANZACS-QI 38).
Wang TKM; Kerr A; Kasargod C; Chan D; Cicovic S; Dimalapang E; Webster M; Somaratne J
Cardiovasc Revasc Med; 2020 May; 21(5):573-579. PubMed ID: 31481307
[TBL] [Abstract][Full Text] [Related]
19. Long-term outcomes after percutaneous coronary interventions in cancer survivors.
Landes U; Kornowski R; Bental T; Assali A; Vaknin-Assa H; Lev E; Iakobishvili Z
Coron Artery Dis; 2017 Jan; 28(1):5-10. PubMed ID: 27622995
[TBL] [Abstract][Full Text] [Related]
20. Impact of 3-dimensional bifurcation angle on 5-year outcome of patients after percutaneous coronary intervention for left main coronary artery disease: a substudy of the SYNTAX trial (synergy between percutaneous coronary intervention with taxus and cardiac surgery).
Girasis C; Farooq V; Diletti R; Muramatsu T; Bourantas CV; Onuma Y; Holmes DR; Feldman TE; Morel MA; van Es GA; Dawkins KD; Morice MC; Serruys PW
JACC Cardiovasc Interv; 2013 Dec; 6(12):1250-60. PubMed ID: 24355115
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
